Oracle (NYSE:ORCL) PT Lowered to $104.00 at DA Davidson

Oracle (NYSE:ORCLFree Report) had its target price trimmed by DA Davidson from $115.00 to $104.00 in a research report released on Tuesday, Marketbeat.com reports. The brokerage currently has a neutral rating on the enterprise software provider’s stock. DA Davidson also issued estimates for Oracle’s Q2 2024 earnings at $1.07 EPS, FY2024 earnings at $4.33 EPS and FY2025 earnings at $4.80 EPS.

A number of other analysts also recently commented on ORCL. Deutsche Bank Aktiengesellschaft boosted their target price on Oracle from $120.00 to $135.00 in a research report on Tuesday, June 13th. VNET Group restated a maintains rating on shares of Oracle in a research report on Tuesday, June 13th. Evercore ISI upped their price objective on Oracle from $95.00 to $110.00 in a research report on Monday, June 12th. Wolfe Research upped their price objective on Oracle from $130.00 to $140.00 in a research report on Tuesday, June 13th. Finally, Mizuho upped their price objective on Oracle from $116.00 to $150.00 in a research report on Tuesday, June 13th. Twelve investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, Oracle presently has an average rating of Moderate Buy and a consensus target price of $122.22.

View Our Latest Stock Analysis on Oracle

Oracle Trading Up 1.6 %

Shares of ORCL stock opened at $113.66 on Tuesday. The business’s fifty day moving average price is $117.33 and its 200 day moving average price is $105.89. Oracle has a 1-year low of $60.78 and a 1-year high of $127.54. The firm has a market capitalization of $308.50 billion, a PE ratio of 37.14, a P/E/G ratio of 3.48 and a beta of 1.00. The company has a debt-to-equity ratio of 55.54, a current ratio of 0.91 and a quick ratio of 0.91.

Oracle (NYSE:ORCLGet Free Report) last posted its earnings results on Monday, September 11th. The enterprise software provider reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $1.15 by $0.04. The company had revenue of $12.45 billion for the quarter, compared to the consensus estimate of $12.48 billion. Oracle had a negative return on equity of 470.73% and a net margin of 17.02%. Oracle’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.81 earnings per share. As a group, sell-side analysts forecast that Oracle will post 4.5 EPS for the current fiscal year.

Oracle Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 26th. Shareholders of record on Thursday, October 12th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Wednesday, October 11th. This represents a $1.60 dividend on an annualized basis and a yield of 1.41%. Oracle’s dividend payout ratio (DPR) is presently 52.29%.

Insider Buying and Selling at Oracle

In other Oracle news, EVP Maria Smith sold 1,320 shares of the firm’s stock in a transaction that occurred on Wednesday, July 5th. The stock was sold at an average price of $116.78, for a total transaction of $154,149.60. Following the completion of the sale, the executive vice president now owns 20,280 shares in the company, valued at approximately $2,368,298.40. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Oracle news, EVP Maria Smith sold 1,320 shares of the stock in a transaction that occurred on Wednesday, July 5th. The stock was sold at an average price of $116.78, for a total transaction of $154,149.60. Following the transaction, the executive vice president now owns 20,280 shares of the company’s stock, valued at approximately $2,368,298.40. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Edward Screven sold 354,837 shares of the stock in a transaction that occurred on Tuesday, June 20th. The stock was sold at an average price of $123.39, for a total value of $43,783,337.43. Following the transaction, the insider now directly owns 2,543,033 shares in the company, valued at approximately $313,784,841.87. The disclosure for this sale can be found here. Insiders sold a total of 3,949,837 shares of company stock worth $482,142,887 in the last 90 days. 43.70% of the stock is owned by corporate insiders.

Institutional Trading of Oracle

Hedge funds have recently made changes to their positions in the stock. Atlas Wealth LLC bought a new stake in shares of Oracle in the 4th quarter worth approximately $315,000. CoreCap Advisors LLC lifted its holdings in shares of Oracle by 22.4% in the 4th quarter. CoreCap Advisors LLC now owns 8,566 shares of the enterprise software provider’s stock worth $700,000 after purchasing an additional 1,565 shares during the last quarter. Resources Investment Advisors LLC. lifted its holdings in shares of Oracle by 34.0% in the 1st quarter. Resources Investment Advisors LLC. now owns 18,153 shares of the enterprise software provider’s stock worth $1,687,000 after purchasing an additional 4,606 shares during the last quarter. Narus Financial Partners LLC bought a new stake in shares of Oracle in the 1st quarter worth approximately $327,000. Finally, Garde Capital Inc. lifted its holdings in shares of Oracle by 8.2% in the 1st quarter. Garde Capital Inc. now owns 7,114 shares of the enterprise software provider’s stock worth $661,000 after purchasing an additional 540 shares during the last quarter. Institutional investors own 42.44% of the company’s stock.

About Oracle

(Get Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

See Also

Analyst Recommendations for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.